当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
AUDENZ, Influenza A (H5N1) Monovalent Vaccine, Adjuvanted
药品名称
AUDENZ, Influenza A (H5N1) Monovalent Vaccine, Adjuvanted
承诺描述
To conduct a study (Study V130_10) to evaluate the safety and immunogenicity of Flucelvax Quadrivalent in pediatric subjects 6 months to less than 4 years of age.